다한증 치료 시장 : 시장 규모, 점유율, 성장 분석, 유형별, 치료법별, 연령별, 최종 사용자별, 지역별 - 산업 예측(2025-2032년)

Global Hyperhidrosis Treatment Market size was valued at USD 671.2 million in 2023 and is poised to grow from USD 707.44 million in 2024 to USD 1077.5 million by 2032, growing at a CAGR of 5.4% during the forecast period (2025-2032).

The hyperhidrosis treatment market is witnessing significant growth driven by heightened R&D investment and a rising prevalence of secondary hyperhidrosis disorders. Antiperspirants and topical solutions remain the frontline therapies as no permanent cure exists. The growing patient preference for innovative treatment options has spurred companies to enhance their offerings. Currently, hyperhidrosis affects about 3% of the U.S. population, according to a study published by Jared Brackenrich in October 2021, underscoring the condition's impact on social, psychological, and vocational functioning. Additionally, promising therapies in the pipeline, favorable reimbursement policies, and increasing public awareness are likely to fuel demand. Notably, Brickell Biotech's Phase 3 trials of sofpironium bromide gel indicate a strong future potential for advanced hyperhidrosis treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hyperhidrosis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hyperhidrosis Treatment Market Segmental Analysis

Global Hyperhidrosis Treatment Market is segmented by Type, Treatment, Age, End-user and region. Based on Type, the market is segmented into Axillary hyperhidrosis, Palmar hyperhidrosis, Plantar hyperhidrosis and Other types. Based on Treatment, the market is segmented into Topical treatment, Oral medication, Botulinum toxin injections, Iontophoresis and Surgical treatment. Based on Age, the market is segmented into Up to 50 years and Above 50 years. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers, Dermatology clinics and Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hyperhidrosis Treatment Market

The Global Hyperhidrosis Treatment market is driven by a growing interest among healthcare providers in exploring advanced therapies such as radiofrequency microneedling for hyperhidrosis patients. Researchers are particularly focused on assessing the long-term effectiveness of fractional microneedle radiofrequency treatments for individuals with primary axillary hyperhidrosis, utilizing the hyperhidrosis disease severity scale (HDSS) to measure significant improvements post-treatment. Additionally, tap water iontophoresis is gaining traction, demonstrating notable results in clinical trials for patients suffering from plantar and palmar hyperhidrosis. Innovations in treatment options are being propelled by recent successful studies, including the positive Phase 3 results from Brickell Biotech Inc. regarding sofpironium bromide gel, highlighting the market's potential for growth and enhanced patient quality of life.

Restraints in the Global Hyperhidrosis Treatment Market

The Global Hyperhidrosis Treatment market faces notable challenges, one of which is the limited duration of effectiveness associated with Botulinum toxin injections; patients often develop a reduced response to these treatments over time. Additionally, the financial implications and emotional strain on patients pose significant obstacles, as many insurance providers do not reimburse expenses related to hyperhidrosis treatments. This lack of coverage not only adds to the economic burden for individuals seeking relief but also contributes to their psychological distress, potentially leading to decreased treatment adherence and limiting market growth opportunities in this sector.

Market Trends of the Global Hyperhidrosis Treatment Market

The Global Hyperhidrosis Treatment market is witnessing significant growth, driven by an increasing awareness of excessive sweating conditions and the effectiveness of advanced treatment options like onabotulinumtoxinA (Botox). With its clinically proven ability to reduce sweating by 82-87% and long-lasting effects that can endure up to 14 months, Botox has become a preferred treatment choice among patients. The market is further propelled by innovations in minimally invasive procedures, a growing prevalence of hyperhidrosis, and a rise in disposable income allowing for aesthetic treatments. As demand expands, the market is poised for continued advancement through research and new therapeutic options.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Hyperhidrosis Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Axillary hyperhidrosis
• Palmar hyperhidrosis
• Plantar hyperhidrosis
• Other types

Global Hyperhidrosis Treatment Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Topical treatment
• Oral medication
  • Anticholinergics
  • Other oral medications
• Botulinum toxin injections
• Iontophoresis
• Surgical treatment

Global Hyperhidrosis Treatment Market Size by Age & CAGR (2025-2032)

• Market Overview
• Up to 50 years
• Above 50 years

Global Hyperhidrosis Treatment Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Dermatology clinics
• Other end-users

Global Hyperhidrosis Treatment Market Size & CAGR (2025-2032)

• North America (Type, Treatment, Age, End-user)
  • US
  • Canada
• Europe (Type, Treatment, Age, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Age, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Age, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Age, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AbbVie Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanor Healthcare Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brickell Biotech Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dermadry Laboratories Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dermavant Sciences Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hugel, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eirion Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaken Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maruho Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• miraDry, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SweatBlock (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roivant Sciences Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theravida, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. August Wolff GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NovaMedica (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations